Global Spiroxamine Market is projected to grow at a CAGR of 3.9%

Date: 2016-09-14

Spiroxamine is a particularly effective in the control of Ersiphe graminis on wheat and barley. The product block fungal sterol biosynthesis by inhibition of delta 14 reductase, as opposed to the azole fungicides which act by blocking C14 demethylation. It acts preventatively by blocking the formation of the appressoria. When used as a curative treament, the haustoria formed in the plant tissues are distorted. The product also destroys mycelia and conidia present on the surface of the plant. Spiroxamine penetrates the leaf and is translocated acropetally to the leaf tip.

In field trials, the product has shown comparable activity to DIM’s, morpholines, sulfur and piperidines. In cereals, the lower application rate is particularly suitable for higher growth stages; higher rates are required for good persistance of activity. In vines, Prosper and Hoggar should be applied at 14-day intervals, but not more than three times a season. The product has been shown not to affect either the fermentation or the organoleptic qualities of wines.  On hops, a maximum of two applications can be made per season, at 28 days intervals, and at least 28 days pre-harvest.

Bayer states that no cross-resistance has been observed with strobilurins, quinolines, triazoles and piperidines. The company recommends its use in resistance management programmes.

The global spiroxamine market is projected to grow at a CAGR of 3.9% over 2016 to 2020.
Global Spiroxamine Market Share Analysis by geography as following


Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 1-510-400-8520

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample